Post by
MrMugsy on Dec 23, 2023 2:26pm
Merry Christmas All
What a great pivot it's been.
New formulation, safer product and more control. Let's see where they take that in 2024 as we go to P2 for Acute and as they use DILIsym to plan out a Chronic path.
Remember - a simple chronic path might be all about a Naproxen regimen where you intersperse a little OTENA. On a more complex note, you'd do it all with OTENA alone. There seems to be an infinite number of combinations between these two extremes. I know ... I've been saying that for 2 years. It makes even more sense now than ever before.
Where do we settle with our web of patents?
- base IP for H2S
- new formulation for OTENA
- complex regimen control for Acute and Chronic
All of this leads to completing P2 Acute, filing for breakthrough therapy, partnering up in other geographic regions and setting a path forward for Chronic?
What a gem if we can do it. The pivot is done and they performed as well as can be expected. Where does it take us from here?
Very exciting - and - Merry Christmas. to all of you! Throw in a little Bruce Willis Christmas movie in, a little Yippy-Ki-Yay ... that will set the holiday tone ... and ... kick back with a few drinks while John Maclean saves Christmas for many on the 30th floor of the Nokatomi Tower.
Ho-Ho-Ho